IL-21 induces inhibitor of differentiation 2 and leads to complete abrogation of anaphylaxis in mice

Journal of Immunology

Volumn 179, Issue 12, 2007, Pages 8554-8561

  Kishida, Tsunao ^a   Hiromura, Yayoi ^a   Shin Ya, Masaharu ^a   Asada, Hidetsugu ^a   Kuriyama, Hiroko ^a   Sugai, Manabu ^b   Shimizu, Akira ^b   Yokota, Yoshifumi ^c   Hama, Takemitsu ^a   Imanishi, Jiro ^a   Hisa, Yasuo ^a   Mazda, Osam ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; IMMUNOGLOBULIN E; INHIBITOR OF DIFFERENTIATION 2; INTERLEUKIN 21; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 21; UNCLASSIFIED DRUG; INTERLEUKIN DERIVATIVE;

ALLERGIC REACTION; ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BODY TEMPERATURE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE EXPRESSION; GENE FUNCTION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; IMMUNOREGULATION; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PEANUT ALLERGY; PLASMID; PRIORITY JOURNAL; REGULATORY MECHANISM; SPLEEN CELL; TARGET CELL; ANIMAL; GENE REARRANGEMENT; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY;

ANAPHYLAXIS; ANIMALS; B-LYMPHOCYTES; GENE EXPRESSION; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN E; INHIBITOR OF DIFFERENTIATION PROTEIN 2; INTERLEUKINS; MICE; MICE, KNOCKOUT; PEANUT HYPERSENSITIVITY;

EID: 40049086595     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.12.8554     Document Type: Article

References (58)

1. Fahy, J. V. 2006. Anti-IgE: lessons learned from effects on airway inflammation and asthma exacerbation. J. Allergy Clin. Immunol. 117: 1230-1232.
2. Sicherer, S. H., and D. Y. Leung. 2007. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects. J. Allergy Clin. Immunol. 119: 1462-1469.
3. Parrish-Novak, J., S. R. Dillon, A. Nelson, A. Hammond, C. Sprecher, J. A. Gross, J. Johnston, K. Madden, W. Xu, J. West, et al. 2000. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 408: 57-63.
4. Habib, T., S. Senadheera, K. Weinberg, and K. Kaushansky. 2002. The common γ chain (γc) is a required signaling component of the IL-21 receptor and supports IL-21-induced cell proliferation via JAK3. Biochemistry 41: 8725-8731.
5. Leonard, W. J., and R. Spolski. 2005. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 5: 688-698.
6. Nurieva, R., X. O. Yang, G. Martinez, Y. Zhang, A. D. Panopoulos, L. Ma, K. Schluns, Q. Tian, S. S. Watowich, A. M. Jetten, and C. Dong. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448: 480-483.
7. Korn, T., E. Bettelli, W. Gao, A. Awasthi, A. Jager, T. B. Strom, M. Oukka, and V. K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448: 484-487.
8. Zhou, L., I. I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D. E. Levy, W. J. Leonard, and D. R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8: 967-974.
9. Ozaki, K., R. Spolski, R. Ettinger, H. P. Kim, G. Wang, C. F. Qi, P. Hwu, D. J. Shaffer, S. Akilesh, D. C. Roopenian, et al. 2004. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J. Immunol. 173: 5361-5371.
10. Pene, J., J. F. Gauchat, S. Lecart, E. Drouet, P. Guglielmi, V. Boulay, A. Delwail, D. Foster, J. C. Lecron, and H. Yssel. 2004. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cells. J. Immunol. 172: 5154-5157.
11. Ettinger, R., G. P. Sims, A. M. Fairhurst, R. Robbins, Y. S. da Silva, R. Spolski, W. J. Leonard, and P. E. Lipsky. 2005. IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175: 7867-7879.
12. Jin, H., R. Carrio, A. Yu, and T. R. Malek. 2004. Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis. J. Immunol. 173: 657-665.
13. Good, K. L., V. L. Bryant, and S. G. Tangye. 2006. Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J. Immunol. 177: 5236-5247.
14. Mehta, D. S., A. L. Wurster, and M. J. Grusby. 2004. Biology of IL-21 and the IL-21 receptor. Immunol. Rev. 202: 84-95.
15. Mehta, D. S., A. L. Wurster, M. J. Whitters, D. A. Young, M. Collins, and M. J. Grusby. 2003. IL-21 induces the apoptosis of resting and activated primary B cells. J. Immunol. 170: 4111-4118.
16. Ozaki, K., R. Spolski, C. G. Feng, C. F. Qi, J. Cheng, A. Sher, H. C. Morse, III, C. Liu, P. L. Schwartzberg, and W. J. Leonard. 2002. A critical role for IL-21 in regulating immunoglobulin production. Science 298: 1630-1634.
17. Shang, X. Z., K. Y. Ma, J. Radewonuk, J. Li, X. Y. Song, D. E. Griswold, E. Emmell, and L. Li. 2006. IgE isotype switch and IgE production are enhanced in IL-21-deficient but not IFN-γ-deficient mice in a Th2-biased response. Cell. Immunol. 241: 66-74.
18. Suto, A., H. Nakajima, K. Hirose, K. Suzuki, S. Kagami, Y. Seto, A. Hoshimoto, Y. Saito, D. C. Foster, and I. Iwamoto. 2002. Interleukin 21 prevents antigen-induced IgE production by inhibiting germ line Cε transcription of IL-4-stimulated B cells. Blood 100: 4565-4573.
19. Wood, N., K. Bourque, D. D. Donaldson, M. Collins, D. Vercelli, S. J. Goldman, and M. T. Kasaian. 2004. IL-21 effects on human IgE production in response to IL-4 or IL-13. Cell. Immunol. 231: 133-145.
20. Caven, T. H., A. Shelburne, J. Sato, Y. Chan-Li, S. Becker, and D. H. Conrad. 2005. IL-21 dependent IgE production in human and mouse in vitro culture systems is cell density and cell division dependent and is augmented by IL-10. Cell. Immunol. 238: 123-134.
21. Pene, J., L. Guglielmi, J. F. Gauchat, N. Harrer, M. Woisetschlager, V. Boulay, J. M. Fabre, P. Demoly, and H. Yssel. 2006. IFN-γ-mediated inhibition of human IgE synthesis by IL-21 is associated with a polymorphism in the IL-21R gene. J. Immunol. 177: 5006-5013.
22. Harada, M., K. Magara-Koyanagi, H. Watarai, Y. Nagata, Y. Ishii, S. Kojo, S. Horiguchi, Y. Okamoto, T. Nakayama, N. Suzuki, et al. 2006. IL-21-induced Bε cell apoptosis mediated by natural killer T cells suppresses IgE responses. J. Exp. Med. 203: 2929-2937.
23. Hiromura, Y., T. Kishida, H. Nakano, T. Hama, J. Imanishi, Y. Hisa, and O. Mazda. 2007. IL-21 administration into the nostril alleviates murine allergic rhinitis. J. Immunol. 179: 7157-7165.
24. Roy, K., H. Q. Mao, S. K. Huang, and K. W. Leong. 1999. Oral gene delivery with chitosan: DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5: 387-391.
25. Kishida, T., H. Asada, Y. Itokawa, F. D. Cui, M. Shin-Ya, S. Gojo, K. Yasutomi, Y. Ueda, H. Yamagishi, J. Imanishi, and O. Mazda. 2003. Interleukin (IL)-21 and IL-15 genetic transfer synergistically augments therapeutic antitumor immunity and promotes regression of metastatic lymphoma. Mol. Ther. 8: 552-558.
26. Nakano, H., T. Kishida, H. Asada, M. Shin-Ya, T. Shinomiya, J. Imanishi, T. Shimada, S. Nakai, M. Takeuchi, Y. Hisa, and O. Mazda. 2006. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma. J. Gene Med. 8: 90-99.
27. Liu, F., Y. Song, and D. Liu. 1999. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6: 1258-1266.
28. Zhang, G., V. Budker, and J. A. Wolff. 1999. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10: 1735-1737.
29. Cui, F. D., T. Kishida, S. Ohashi, H. Asada, K. Yasutomi, E. Satoh, T. Kubo, S. Fushiki, J. Imanishi, and O. Mazda. 2001. Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors. Gene Ther. 8: 1508-1513.
30. Linehan, L. A., W. D. Warren, P. A. Thompson, M. J. Grusby, and M. T. Berton. 1998. STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J. Immunol. 161: 302-310.
31. Sugai, M., H. Gonda, T. Kusunoki, T. Katakai, Y. Yokota, and A. Shimizu. 2003. Essential role of Id2 in negative regulation of IgE class switching. Nat. Immunol. 4: 25-30.
32. Muramatsu, M., K. Kinoshita, S. Fagarasan, S. Yamada, Y. Shinkai, and T. Honjo. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
33. Honjo, T., H. Nagaoka, R. Shinkura, and M. Muramatsu. 2005. AID to overcome the limitations of genomic information. Nat. Immunol. 6: 655-661.
34. Gonda, H., M. Sugai, Y. Nambu, T. Katakai, Y. Agata, K. J. Mori, Y. Yokota, and A. Shimizu. 2003. The balance between Pax5 and Id2 activities is the key to AID gene expression. J. Exp. Med. 198: 1427-1437.
35. Honjo, T., K. Kinoshita, and M. Muramatsu. 2002. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol. 20: 165-196.
36. Longerich, S., U. Basu, F. Alt, and U. Storb. 2006. AID in somatic hypermutation and class switch recombination. Curr. Opin. Immunol. 18: 164-174.
37. Qiu, G., and J. Stavnezer. 1998. Overexpression of BSAP/Pax-5 inhibits switching to IgA and enhances switching to IgE in the I. 29 μ B cell line. J. Immunol. 161: 2906-2918.
38. Sayegh, C. E., M. W. Quong, Y. Agata, and C. Murre. 2003. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat. Immunol. 4: 586-593.
39. Sugai, M., H. Gonda, Y. Nambu, Y. Yokota, and A. Shimizu. 2004. Role of Id proteins in B lymphocyte activation: new insights from knockout mouse studies. J. Mol. Med. 82: 592-599.
40. Fenghao, X., A. Saxon, A. Nguyen, Z. Ke, D. Diaz-Sanchez, and A. Nel. 1995. Interleukin 4 activates a signal transducer and activator of transcription (Stat) protein which interacts with an interferon-γ activation site-like sequence upstream of the I ε exon in a human B cell line: evidence for the involvement of Janus kinase 3 and interleukin-4 Stat. J. Clin. Invest. 96: 907-914.
41. Dedeoglu, F., B. Horwitz, J. Chaudhuri, F. W. Alt, and R. S. Geha. 2004. Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NF-κB. Int. Immunol. 16: 395-404.
42. Thienes, C. P., L. De Monte, S. Monticelli, M. Busslinger, H. J. Gould, and D. Vercelli. 1997. The transcription factor B cell-specific activator protein (BSAP) enhances both IL-4- and CD40-mediated activation of the human ε germline promoter. J. Immunol. 158: 5874-5882.
43. Quong, M. W., D. P. Harris, S. L. Swain, and C. Murre. 1999. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J. 18: 6307-6318.
44. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380: 627-630.
45. + dendritic cell subset in Id2-deficient mice. J. Allergy Clin. Immunol. 111: 136-142.
46. Harris, M. B., C. C. Chang, M. T. Berton, N. N. Danial, J. Zhang, D. Kuehner, B. H. Ye, M. Kvatyuk, P. P. Pandolfi, G. Cattoretti, et al. 1999. Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iε transcription and immunoglobulin E switching. Mol. Cell. Biol. 19: 7264-7275.
47. Snapper, C. M., and J. J. Mond. 1993. Towards a comprehensive view of immunoglobulin class switching. Immunol. Today 14: 15-17.
48. Deenick, E. K., J. Hasbold, and P. D. Hodgkin. 2005. Decision criteria for resolving isotype switching conflicts by B cells. Eur. J. Immunol. 35: 2949-2955.
49. Hecker, M., A. Bohnert, I. R. Konig, G. Bein, and H. Hackstein. 2003. Novel genetic variation of human interleukin-21 receptor is associated with elevated IgE levels in females. Genes Immun. 4: 228-233.
50. Yokota, Y. 2001. Id and development. Oncogene 20: 8290-8298.
51. Murre, C. 2005. Helix-loop-helix proteins and lymphocyte development. Nat. Immunol. 6: 1079-1086.
52. Lasorella, A., T. Uo, and A. Iavarone. 2001. Id proteins at the cross-road of development and cancer. Oncogene 20: 8326-8333.
53. Ruzinova, M. B., and R. Benezra. 2003. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 13: 410-418.
54. Yokota, Y., A. Mansouri, S. Mori, S. Sugawara, S. Adachi, S. Nishikawa, and P. Gruss. 1999. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397: 702-706.
55. Ikawa, T., S. Fujimoto, H. Kawamoto, Y. Katsura, and Y. Yokota. 2001. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc. Natl. Acad. Sci. USA 98: 5164-5169.
56. Hacker, C., R. D. Kirsch, X. S. Ju, T. Hieronymus, T. C. Gust, C. Kuhl, T. Jorgas, S. M. Kurz, S. Rose-John, Y. Yokota, and M. Zenke. 2003. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 4: 380-386.
57. Kim, J. K., M. Takeuchi, and Y. Yokota. 2004. Impairment of intestinal intraepithelial lymphocytes in Id2 deficient mice. Gut 53: 480-486.
58. + T cell immunity. Nat. Immunol. 7: 1317-1325.